-
Company Insights
New![]()
Innovation and Patenting activity of Computer Programs and Systems Inc Q3 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Computer Programs and Systems Inc Q3 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report...
-
Product Insights
New![]()
Unitywater – Aura and Harmony Trunk Infrastructure Program: Aura Water Project – Queensland
Equip yourself with the essential tools needed to make informed and profitable decisions with our Unitywater – Aura and Harmony Trunk Infrastructure Program: Aura Water Project – Queensland report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to buy Acquire a...
-
Track & Monitor
![]()
Blockchain in travel & tourism: loyalty programs blockchain
Why settle for outdated information when you can stay ahead of the curve with our comprehensive report? Our team of industry experts has meticulously researched and analyzed the latest trends, innovations, and emerging technologies in the travel & tourism industry’s loyalty programs blockchain within Blockchain innovations. By leveraging our report, you'll gain invaluable insights that can revolutionize your business strategies and give you a competitive edge. Why Choose Our Report? Unparalleled Expertise: Our research team consists of seasoned analysts with...
-
Product Insights
![]()
Innovation in Payments – Reward Programs, Payment Loyalty by Region and Consumer Attitudes
Innovation in Payments Report Overview Loyalty programs have developed from a simple, unique premise to complex, omnichannel, and personalized programs. Reward points are a key method providers use to attract new customers. Such programs encourage switching, cross-selling, and retention. Most reward programs are focused on either cashback or points. The innovation in payments report covers the latest innovations by businesses in the payment sector pertaining to reward programs, payment loyalties by region, and consumer attitudes toward loyalty. Furthermore, this report...
-
Sector Analysis
![]()
Missiles and Missile Defense Systems Market Size and Trend Analysis by Segments, Programs, Competitive Landscape and Forecast to 2033
Missile Defense Systems Market Overview The global missiles and missile defense systems (MMDS) market is valued at $45.2 billion in 2023 and will grow at a compound annual growth rate (CAGR) of more than 4% during 2023-2033. The MMDS market will be driven by the rise in air defense modernization and advanced precision strike missile procurement programs by key defense spending countries, such as the US, Russia, China, India, Poland, and the UK, among others. The increased focus on the...
-
Sector Analysis
![]()
Artillery Systems Market Size and Trend Analysis Including Segments, Programs, Competitive Landscape and Forecast to 2033
Explore actionable market insights from the following data in our ‘Artillery Systems Market’ report: Market Size and Drivers: Detailed analysis during 2023-2033, including the demand drivers and growth stimulators. It also provides a snapshot of the spending and modernization patterns of different regions around the world. Recent Developments and Industry Challenges: Insights into technological developments and a detailed analysis of the existing artillery projects being executed and planned worldwide. It also provides trends of the changing industry structure and the...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Acrixolimab in Endometrial Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Acrixolimab in Endometrial Cancer Drug Details: Acrixolimab (YBL-006) is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Acrixolimab in Anal Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Acrixolimab in Anal Cancer Drug Details: Acrixolimab (YBL-006) is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Acrixolimab in Renal Cell Carcinoma
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Acrixolimab in Renal Cell Carcinoma Drug Details: Acrixolimab (YBL-006) is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Acrixolimab in Nasopharyngeal Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Acrixolimab in Nasopharyngeal Cancer Drug Details: Acrixolimab (YBL-006) is under development for the treatment of...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.